How CHAI Affects Your Body: Multi-System Symptoms
At a Glance
CTLA4 haploinsufficiency (CHAI) can affect several body systems, causing blood-cell problems, low protective antibodies, lung inflammation, digestive symptoms, and neurological changes. Symptoms vary, may evolve, and should be evaluated by a coordinated care team.
One of the most defining characteristics of CTLA4 haploinsufficiency (CHAI) is its “multi-system” nature. Because the CTLA-4 protein regulates the immune system, dysregulation allows immune cells to move into and affect almost any part of the body [1].
It is important to remember that no two people with CHAI are exactly alike. You may experience several of these symptoms, or perhaps only one. Symptoms can also change or evolve over many years [2]. Furthermore, the symptoms described below can also be caused by unrelated infections or medication side effects, so they require evaluation rather than assumption.
Blood and the Immune System
The most common symptoms of CHAI involve the blood and the immune system itself. Doctors often see a situation where the immune system is both overactive and failing to protect the body.
- Autoimmune Cytopenias (62% in one cohort): This occurs when the immune system mistakenly attacks and destroys blood cells [1]. Common forms include Immune Thrombocytopenia (ITP) (low platelets, leading to easy bruising or bleeding) and Autoimmune Hemolytic Anemia (AIHA) (low red blood cells, causing fatigue and paleness) [3][4]. When both occur together, it is known as Evans Syndrome [4].
- Hypogammaglobulinemia (84% in one cohort): This is a technical term for low levels of protective antibodies (immunoglobulins) [1]. This leaves you more vulnerable to recurrent infections, such as pneumonia or ear infections [5].
- Lymphoproliferation (73% in one cohort): This is the term for an accumulation of immune cells that causes parts of the lymphatic system to swell [1]. This commonly shows up as swollen lymph nodes (lymphadenopathy), an enlarged spleen (splenomegaly), or an enlarged liver (hepatomegaly) [6][7].
Lung and Respiratory Involvement
Respiratory symptoms are reported in approximately 68% of affected individuals in some studies [1]. The immune system can cause inflammation in the lung tissue that isn’t caused by an infection. On a CT scan, doctors may look for nonspecific imaging findings that require specialist interpretation [8][9]:
- Pulmonary Nodules: Spots that can reflect inflammation, but could also be infection.
- Ground-Glass Opacities: Hazy areas that look like “fog” on the scan, which can reflect infection, inflammation, or hemorrhage.
- Bronchiectasis: Damage and scarring of the airways, often from repeated infections.
- GLILD: A specific type of lung disease (Granulomatous-Lymphocytic Interstitial Lung Disease) where granulomatous and lymphocytic inflammation invades the lung tissue [9].
Digestive System and Nutrition
Gastrointestinal (GI) issues affect about 59% of patients in some cohorts [1]. This is often called immune-mediated enteropathy. The immune system attacks the lining of the gut, which can lead to [10][11]:
- Chronic Diarrhea: Severe, ongoing diarrhea that requires careful management.
- Malabsorption: The body’s inability to take in nutrients from food.
- Nutritional Deficiencies: In severe cases, significant unintentional weight loss and marked wasting can occur due to the body’s high-inflammatory state and poor nutrient absorption [12].
Neurological and Brain Involvement
Neurological symptoms occur in roughly 29% of cases [1]. These can be some of the most complex symptoms to manage because, in one specific study, MRI lesions were sometimes clinically silent—meaning they showed up on an MRI before symptoms were felt [13]. Manifestations can include:
- Inflammatory Lesions: Areas of inflammation in the brain or spinal cord that can mimic other diseases like multiple sclerosis [13][14].
- Headaches and Seizures: Resulting from inflammation or changes in the central nervous system [13][15].
- Vision or Coordination Changes: Occasionally, patients may experience balance issues (ataxia) or changes in their sight [13].
Because CHAI can affect so many areas, your care will likely involve a team of specialists—including immunologists, hematologists, and gastroenterologists—who work together to monitor these different systems [16].
Common questions in this guide
What parts of the body can CTLA4 haploinsufficiency affect?
What blood and immune problems can CHAI cause?
What lung symptoms or scan findings are linked to CHAI?
How can CHAI affect digestion and nutrition?
Can CHAI cause headaches or other brain symptoms?
How is multi-system CHAI monitored?
How can doctors tell a CHAI flare from an infection?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Possible other causes
Could my symptoms be caused by an infection or a medication side effect?
Lung involvement
Would a CT scan be used to look at my lungs?
Care team
Who would be on the team to monitor these different body systems?
Get notified when new evidence is published on Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
Schwab C, Gabrysch A, Olbrich P, et al.
The Journal of allergy and clinical immunology 2018; (142(6)):1932-1946 doi:10.1016/j.jaci.2018.02.055.
PMID: 29729943 - 2
Clinical and genetic features of CTLA-4 haploinsufficiency: a prospective study in China.
Liu G, Zhang J, Wu D, et al.
BMC rheumatology 2026; (10(1)).
PMID: 41904601 - 3
Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.
Besnard C, Levy E, Aladjidi N, et al.
Clinical immunology (Orlando, Fla.) 2018; (188()):52-57 doi:10.1016/j.clim.2017.12.009.
PMID: 29330115 - 4
A Rare Central Nervous System Involvement Due to CTLA-4 Gene Defect.
Rovshanov S, Göçmen R, Barişta İ, et al.
Noro psikiyatri arsivi 2022; (59(3)):248-252 doi:10.29399/npa.27900.
PMID: 36160072 - 5
Case Report: The first Mainland Chinese case of CTLA4 c.529dupT haploinsufficiency with a 38-year diagnostic delay.
Gu X, Guo J, Li L, et al.
Frontiers in immunology 2026; (17()):1899668 doi:10.3389/fimmu.2026.1899668.
PMID: 42819059 - 6
CTLA-4 gene mutation and multiple sclerosis: A case report and literature review.
Lin TW, Hu YC, Yang YH, et al.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2022; (55(3)):545-548 doi:10.1016/j.jmii.2021.10.009.
PMID: 34824019 - 7
Clinical Challenges: Identification of Patients With Novel Primary Immunodeficiency Syndromes.
Buchbinder D, Seppanen M, Rao VK, et al.
Journal of pediatric hematology/oncology 2018; (40(5)):e319-e322 doi:10.1097/MPH.0000000000001003.
PMID: 29200144 - 8
Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.
Krone KA, Winant AJ, Vargas SO, et al.
Pediatric pulmonology 2021; (56(7)):2232-2241 doi:10.1002/ppul.25373.
PMID: 33710794 - 9
Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency.
Nishimura M, Miyata J, Tanigaki T, et al.
Internal medicine (Tokyo, Japan) 2023; (62(6)):871-875 doi:10.2169/internalmedicine.0076-22.
PMID: 35945007 - 10
Cytotoxic T Lymphocyte Antigen 4 Haploinsufficiency Presenting As Refractory Celiac-Like Disease: Case Report.
Collen LV, Salgado CA, Bao B, et al.
Frontiers in immunology 2022; (13()):894648 doi:10.3389/fimmu.2022.894648.
PMID: 35935971 - 11
Novel pathogenic CTLA4 missense variant associated with autoimmune enteropathy and systemic immune dysregulation.
Zheng D, Tian C, Ye X, et al.
Frontiers in immunology 2026; (17()):1855020 doi:10.3389/fimmu.2026.1855020.
PMID: 42577265 - 12
Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: A case report.
Musabak U, Erdoğan T, Ceylaner S, et al.
World journal of clinical cases 2023; (11(26)):6176-6182 doi:10.12998/wjcc.v11.i26.6176.
PMID: 37731560 - 13
Two neurologic facets of CTLA4-related haploinsufficiency.
Ayrignac X, Goulabchand R, Jeziorski E, et al.
Neurology(R) neuroimmunology & neuroinflammation 2020; (7(4)) doi:10.1212/NXI.0000000000000751.
PMID: 32499327 - 14
Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report.
Kolcava J, Litzman J, Bednarik J, et al.
Multiple sclerosis and related disorders 2020; (45()):102313 doi:10.1016/j.msard.2020.102313.
PMID: 32623363 - 15
CTLA4 Alteration and Neurologic Manifestations: A New Family with Large Phenotypic Variability and Literature Review.
Genio E, Lecca M, Ciccocioppo R, Errichiello E
Genes 2025; (16(3)) doi:10.3390/genes16030306.
PMID: 40149457 - 16
Primary Immune Regulatory Disorders (PIRD): Tools for Diagnosis and Disease Activity Assessment to Guide Therapy.
Oved JH, Torgerson TR, Chan AY
The journal of allergy and clinical immunology. In practice 2026; (14(7)):1467-1474 doi:10.1016/j.jaip.2026.05.015.
PMID: 42409454
This page is for informational purposes only and does not constitute medical advice. Symptoms such as infection, fatigue, diarrhea, or neurological changes can have other causes, so discuss new or worsening symptoms with your immunology care team.